George A. Pitoc

1.5k total citations
18 papers, 1.2k citations indexed

About

George A. Pitoc is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, George A. Pitoc has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Genetics. Recurrent topics in George A. Pitoc's work include Advanced biosensing and bioanalysis techniques (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). George A. Pitoc is often cited by papers focused on Advanced biosensing and bioanalysis techniques (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). George A. Pitoc collaborates with scholars based in United States and China. George A. Pitoc's co-authors include Bruce A. Sullenger, Christopher P. Rusconi, Juliana M. Layzer, Dougald M. Monroe, Thomas L. Ortel, Danielle Gélinas, Gloria V. Callard, Shahid M. Nimjee, George Quick and Rebekah R. White and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

George A. Pitoc

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George A. Pitoc United States 12 798 176 150 140 133 18 1.2k
Jen‐Chieh Tseng United States 18 1.0k 1.3× 169 1.0× 121 0.8× 273 1.9× 184 1.4× 35 1.6k
Simon D. J. Calaminus United Kingdom 17 378 0.5× 297 1.7× 120 0.8× 33 0.2× 159 1.2× 30 1.2k
So C. Wong United States 18 1.1k 1.4× 113 0.6× 107 0.7× 219 1.6× 92 0.7× 33 1.7k
Carmela Dell’Aversana Italy 20 937 1.2× 71 0.4× 76 0.5× 65 0.5× 119 0.9× 40 1.4k
Staffan Sandgren Sweden 12 871 1.1× 192 1.1× 52 0.3× 108 0.8× 229 1.7× 13 1.3k
Joan Sayós Spain 24 486 0.6× 350 2.0× 87 0.6× 76 0.5× 1.7k 12.8× 46 2.4k
Christina Gamba‐Vitalo United States 13 681 0.9× 136 0.8× 57 0.4× 87 0.6× 193 1.5× 21 996
Juliana M. Layzer United States 12 1.2k 1.4× 179 1.0× 162 1.1× 100 0.7× 130 1.0× 20 1.4k

Countries citing papers authored by George A. Pitoc

Since Specialization
Citations

This map shows the geographic impact of George A. Pitoc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George A. Pitoc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George A. Pitoc more than expected).

Fields of papers citing papers by George A. Pitoc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George A. Pitoc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George A. Pitoc. The network helps show where George A. Pitoc may publish in the future.

Co-authorship network of co-authors of George A. Pitoc

This figure shows the co-authorship network connecting the top 25 collaborators of George A. Pitoc. A scholar is included among the top collaborators of George A. Pitoc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George A. Pitoc. George A. Pitoc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yu, Haixiang, George A. Pitoc, James W. Frederiksen, et al.. (2025). An Aptamer‐Based EXACT Anticoagulant as a Sustainable, Animal‐Free Alternative to Unfractionated Heparin. Advanced Science. 13(4). e09867–e09867.
2.
Nimjee, Shahid M., Fellery de Lange, George A. Pitoc, & Bruce A. Sullenger. (2025). Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair. PubMed. 10(2). 87–98. 1 indexed citations
3.
Yu, Haixiang, James W. Frederiksen, George A. Pitoc, et al.. (2024). Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors. Nature Communications. 15(1). 3977–3977. 6 indexed citations
4.
Özer, İmran, George A. Pitoc, Juliana M. Layzer, et al.. (2022). PEG‐Like Brush Polymer Conjugate of RNA Aptamer That Shows Reversible Anticoagulant Activity and Minimal Immune Response. Advanced Materials. 34(10). e2107852–e2107852. 32 indexed citations
5.
Pitoc, George A., Nancy J. Ganson, Juliana M. Layzer, et al.. (2019). Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers. Cell chemical biology. 26(5). 634–644.e3. 72 indexed citations
6.
Sommerville, Laura, et al.. (2017). Abstract 519: Inhibition of von Willebrand Factor Activity Does Not Delay Cutaneous Wound Healing. Arteriosclerosis Thrombosis and Vascular Biology. 37(suppl_1). 1 indexed citations
7.
Bompiani, Kristin M., et al.. (2014). Probing the Coagulation Pathway with Aptamers Identifies Combinations that Synergistically Inhibit Blood Clot Formation. Chemistry & Biology. 21(8). 935–944. 14 indexed citations
8.
9.
Jain, Shashank, George A. Pitoc, Eda K. Holl, et al.. (2012). Nucleic acid scavengers inhibit thrombosis without increasing bleeding. Proceedings of the National Academy of Sciences. 109(32). 12938–12943. 88 indexed citations
10.
Holman, Patricia J., et al.. (2009). Sarcocystis sp. encephalomyelitis in a cat. Veterinary Clinical Pathology. 39(1). 105–112. 11 indexed citations
11.
Nimjee, Shahid M., Janelle R. Keys, George A. Pitoc, et al.. (2006). A Novel Antidote-Controlled Anticoagulant Reduces Thrombin Generation and Inflammation and Improves Cardiac Function in Cardiopulmonary Bypass Surgery. Molecular Therapy. 14(3). 408–415. 69 indexed citations
12.
Rusconi, Christopher P., J. Devin Roberts, George A. Pitoc, et al.. (2004). Antidote-mediated control of an anticoagulant aptamer in vivo. Nature Biotechnology. 22(11). 1423–1428. 273 indexed citations
13.
Pitoc, George A., et al.. (2003). Mutations within a conserved protein kinase A recognition sequence confer temperature-sensitive and partially defective activities onto mouse c-Rel. Biochemical and Biophysical Research Communications. 307(1). 92–99. 8 indexed citations
14.
Rusconi, Christopher P., Juliana M. Layzer, George A. Pitoc, et al.. (2002). RNA aptamers as reversible antagonists of coagulation factor IXa. Nature. 419(6902). 90–94. 416 indexed citations
15.
Gélinas, Danielle, George A. Pitoc, & Gloria V. Callard. (1998). Isolation of a goldfish brain cytochrome P450 aromatase cDNA:. Molecular and Cellular Endocrinology. 138(1-2). 81–93. 135 indexed citations
16.
White, David W., George A. Pitoc, & Thomas D. Gilmore. (1996). Interaction of the v-Rel Oncoprotein with NF-κB and IκB Proteins: Heterodimers of a Transformation-Defective v-Rel Mutant and NF-κB p52 Are Functional In Vitro and In Vivo. Molecular and Cellular Biology. 16(3). 1169–1178. 16 indexed citations
17.
Jetten, Mike S. M., George A. Pitoc, Maximillian T. Follettie, & Anthony J. Sinskey. (1994). Regulation of phospho(enol)-pyruvate-and oxaloacetate-converting enzymes in Corynebacterium glutamicum. Applied Microbiology and Biotechnology. 41(1). 47–52. 40 indexed citations
18.
Jetten, Mike S. M., George A. Pitoc, Maximillian T. Follettie, & Anthony J. Sinskey. (1994). Regulation of phospho(enol)-pyruvate- and oxaloacetate-converting enzymes in Corynebacterium glutamicum. Applied Microbiology and Biotechnology. 41(1). 47–52. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jen‐Chieh Tseng Breakdown of academic impact, for papers by Simon D. J. Calaminus Breakdown of academic impact, for papers by So C. Wong Breakdown of academic impact, for papers by Carmela Dell’Aversana Breakdown of academic impact, for papers by Staffan Sandgren Breakdown of academic impact, for papers by Joan Sayós Breakdown of academic impact, for papers by Christina Gamba‐Vitalo Breakdown of academic impact, for papers by Juliana M. Layzer
Rankless by CCL
2026